Inventor · disambiguated record
Johan Auwerx
Also filed as: AUWERX JOHAN
21 granted patents·26 pending applications·195 citations·filing 1996–2025
96Inventor score
Files withAMAZENTIS SA16ECOLE POLYTECHNIQUE FED LAUSANNE EPFL10AUWERX JOHAN3LIGAND PHARM INC3TES PHARMA S R L3
Top patents by PatentIndex Score
47 records- 0197US12036205B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2022·Granted Jul 16, 2024·4 cites·21 claims
- 0297US11166937B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2018·Granted Nov 9, 2021·10 cites·18 claims
- 0396US12310943B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2023·Granted May 27, 2025·3 cites·35 claims
- 0496US11903922B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2020·Granted Feb 20, 2024·4 cites·20 claims
- 0596US11234960B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2015·Granted Feb 1, 2022·10 cites·21 claims
- 0696US10857126B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2016·Granted Dec 8, 2020·12 cites·19 claims
- 0795US11931336B2Enhancing autophagy or increasing longevity by administration of urolithinsAMAZENTIS SA·Filed 2021·Granted Mar 19, 2024·4 cites·20 claims
- 0895US10485782B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2016·Granted Nov 26, 2019·14 cites·33 claims
- 0994US11931335B2Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereofAMAZENTIS SA·Filed 2020·Granted Mar 19, 2024·3 cites·30 claims
- 1094US10028932B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2015·Granted Jul 24, 2018·13 cites·40 claims
- 1194US9962366B2Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereofAMAZENTIS SA·Filed 2015·Granted May 8, 2018·13 cites·20 claims
- 1293US9872850B2Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersRINSCH CHRISTOPHER LAWRENCE·Filed 2011·Granted Jan 23, 2018·18 cites·46 claims
- 1391US11020373B2Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereofAMAZENTIS SA·Filed 2013·Granted Jun 1, 2021·11 cites·20 claims
- 1490US2025375415A1Enhancing autophagy or increasing longevity by administration of urolithinsAMAZENTIS SA·Filed 2025·Application pending·0 cites
- 1589US10709724B2Methods of treating mitochondrial dysfunctionECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2018·Granted Jul 14, 2020·6 cites·7 claims
- 1689US2024156777A1Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disordersAMAZENTIS SA·Filed 2024·Application pending·0 cites
- 1785US9180134B2Mitochondrial ribosomal proteins as aging regulatorsAUWERX JOHAN·Filed 2012·Granted Nov 10, 2015·9 cites·17 claims
- 1884US2023390238A1Enhancing autophagy or increasing longevity by administration of urolithinsAMAZENTIS SA·Filed 2023·Application pending·0 cites
- 1981US9708272B2Inhibitors of α-amino-β-carboxymuconic acid semialdehyde decarboxylaseTES PHARMA S R L·Filed 2015·Granted Jul 18, 2017·4 cites·13 claims
- 2077US11254644B2Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylaseTES PHARMA S R L·Filed 2019·Granted Feb 22, 2022·1 cites·17 claims
- 2171US10513499B2Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylaseTES PHARMA S R L·Filed 2017·Granted Dec 24, 2019·1 cites·11 claims
- 2264US2018015069A1Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereofAMAZENTIS SA·Filed 2017·Application pending·0 cites
- 2363US7098025B1Human peroxisome proliferator activated receptor gamma (pparγ) gene regulatory sequences and uses thereforLIGAND PHARM INC·Filed 1998·Granted Aug 29, 2006·27 cites·12 claims
- 2461US6068976AModulators of ob gene and screening methods thereforLIGAND PHARM INC·Filed 1996·Granted May 30, 2000·28 cites·42 claims
- 2560US2022110902A1Methods of treating amyloid-beta peptide diseasesECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2021·Application pending·0 cites
- 2659US2024299420A1Tetracycline derivative-induced mitohormesis mediates disease tolerance against viral infectionsECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2022·Application pending·0 cites
- 2757US2021137959A1Agents and methods using thereof for the prevention and treatment of stem cell muscle disordersECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2021·Application pending·0 cites
- 2856US10905704B2Agents and methods using thereof for the prevention and treatment of stem cell muscle disordersECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2016·Granted Feb 2, 2021·0 cites·6 claims
- 2955US2017182076A1Methods of treating mitochondrial dysfunctionECOLE POLYTECHNIQUE FED DE LAUSANNE (EPFL)·Filed 2016·Application pending·0 cites
- 3055US2024335505A1Products and methods for promoting myogenesisECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2022·Application pending·0 cites
- 3154US2014065099A1Methods of Treating Mitochondrial DysfunctionALVAREZ CARLOS CANTO·Filed 2012·Application pending·0 cites
- 3251US2019358184A1Methods of treating amyloid-beta peptide diseasesECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2017·Application pending·0 cites
- 3350US2008249103A1Sirtuin polymorphisms and methods of use thereofSIRTRIS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3449US2007149466A1Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disordersMILBURN MICHAEL·Filed 2006·Application pending·0 cites
- 3546US2008031968A1Methods for increasing cellular energy expenditureBRIGHAM & WOMENS HOSPITAL·Filed 2006·Application pending·0 cites
- 3646US2006276426A1Human peroxisome proliferator activated receptor gamma (PPARgamma) gene regulatory sequences and uses thereforLIGAND PHARM INC·Filed 2006·Application pending·0 cites
- 3745US2020096524A1Plasma and liver lipid species as biomarkers of fatty liverECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2018·Application pending·0 cites
- 3844US2022288004A1Treatment and prevention of aging related-disease and/or aging by the inhibition of sphingolipidsECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2020·Application pending·0 cites
- 3943US2010055066A1Agent for prophylactic and/or therapeutic treatment of diabetesSUZUKI KAZUO·Filed 2005·Application pending·0 cites
- 4041US2007191259A1Inhibition of s6 kinaze activity for the treatment of insulin resistanceAUWERX JOHAN·Filed 2004·Application pending·0 cites
- 4140US2003104975A1Cofactor-based screening method for nuclear receptor modulators and related modulatorsFiled 2002·Application pending·0 cites
- 4239US2004082623A1Fmoc-l-leucine and derivatives thereof as ppar-gamma agonistsFiled 2001·Application pending·0 cites
- 4338US2019054098A1Agents and methods using thereof for the prevention and treatment of stem cells senescenceECOLE POLYTECHNIQUE FED LAUSANNE EPFL·Filed 2016·Application pending·0 cites
- 4436US2004171689A1Screening method using solid supports modified with self-assembled monolayersFiled 2002·Application pending·0 cites
- 4536US2014147434A1NCoR1 is a Physiological Modulator of Muscle Mass and Oxidative FunctionAUWERX JOHAN·Filed 2012·Application pending·0 cites
- 4634US2017252362A1Methods & compounds useful in hematopoietic stem cell medicineECOLE POLYTECHNIQUE FED DE LAUSANNE (EPFL)·Filed 2015·Application pending·0 cites
- 4723US2002144302A1Novel constructs and vectors for the targeted and inducible expression of genesFiled 1997·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Johan Auwerx files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →